ATAI
we completed a phase a study for and are evaluating next steps for the program | ATAI
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
19 of 33
Similar slides by ATAI
See diffirences between slides (animation)
Investor Presentation
March 2023
we completed a phase a study for and are evaluating next steps for the program | ATAI
Investor Presentation
January 2023
we completed a phase a study for and are evaluating next steps for the program | ATAI
Investor Presentation
November 2022
we aim to develop as a rapid acting with potential for at home use | ATAI
Investor Presentation
October 2022
we aim to develop as a rapid acting with potential for at home use | ATAI
Related slides by other companies
DICE Therapeutics
Investor Presentation
March 2023
phase studies expected to determine optimal dosing regimen and maximal therapeutic effect dice | DICE Therapeutics
Nuvalent
Investor Presentation
October 2022
study design a global phase study of in patients with advanced positive and other solid tumors cane | Nuvalent
BioNTech
Results
November 2020
highlights covid | BioNTech
Oculis
Results
May 2023
next step phase trial stage | Oculis
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io